Clinical trials
Gastric or Gastroesophageal Junction Adenocarcinoma clinical trials
Below are recruiting gastric or gastroesophageal junction adenocarcinoma clinical trials, each written for real people, not researchers. We’re tracking 972 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06172478RecruitingPhase 2
HER3-DXd for advanced solid tumors after prior treatment
This trial tests a new targeted drug called HER3-DXd for people with several types of advanced solid tumors that have stopped responding to standard treatments. The drug is an antibody-drug conjugate, designed to deliver chemotherapy directly to cancer cells that have a protein called HER3 on their surface.
Duarte, CaliforniaAges 18 years+ - NCT07772167Recruiting
Understanding stomach and gut symptoms in functional dyspepsia
This study uses brain scans (MRIs) and a test meal to understand how the brain and stomach communicate in people with functional dyspepsia (ongoing pain or fullness). This could help improve treatments by identifying how people with this condition feel and process stomach sensations differently.
Boston, MassachusettsAges 18–65 - NCT07482345Recruiting
Fasting strategies and anxiety in children having surgery
This study looks at whether different fasting instructions before surgery can help children be more comfortable and less anxious. It involves children having groin or penis surgery and will check their stomach with ultrasound to see how fasting affects them.
Bursa, BursaAges 2–12 - NCT07646574Enrolling by invitation
Non-surgical treatment after immunotherapy for specific gastric cancer
This trial tests whether patients with advanced gastric cancer (a specific type called dMMR/MSI-H) can be treated without surgery after receiving immunotherapy and chemotherapy. The goal is to see if this approach can control the cancer while avoiding the risks of surgery.
Chengdu, SichuanAges 18 years+ - NCT07770113RecruitingPhase 2
Combination treatment for advanced stomach cancer after first-line therapy
This study tests a new combination of drugs (apatinib, nab-paclitaxel, and possibly adebrelimab) for advanced stomach or gastroesophageal junction cancer that has progressed after initial treatment. The goal is to see if this combination can help control the cancer.
Zhengzhou, HenanAges 18–80 - NCT07757165RecruitingPhase 2
Surgery after drug treatment for advanced stomach cancer
This trial is for people with advanced stomach cancer that has shrunk after initial chemotherapy or targeted therapy. It compares whether adding surgery to continued medical treatment is better than staying on medical treatment alone, with the goal of improving outcomes.
ShanghaiAges 18–75 - NCT07600125Recruiting
Stool test to screen for digestive tract cancers
This study tests whether a stool sample can help detect early signs of cancers in the stomach, colon, and related organs. Researchers will compare stool test results with findings from standard camera procedures to see if this non-invasive approach might catch cancer earlier.
Xi'an, ShaanxiAges 18 years+ - NCT07639853Enrolling by invitation
Doctor feedback survey on Concerto Versa coils
This study gathers feedback from doctors who use Concerto Versa detachable coils (small metal devices that help treat brain aneurysms). The survey helps improve how these coils work and are used.
El Paso, TexasAges 22 years+ - NCT06543615Enrolling by invitation
Ultrasound stomach check before surgery in sleeve gastrectomy patients
This study uses ultrasound to measure how much stomach content remains after fasting in people who have had sleeve gastrectomy surgery. It aims to understand if the standard 8-hour fasting period is enough for this group before other surgeries.
Cairo, Cairo GovernorateAges 21–45 - NCT05886218Recruiting
Monitoring nerves and breathing during gastric bypass surgery
This study uses special monitoring to better understand nerve and breathing-related signals during elective gastric bypass surgery. It may help surgeons and anesthesiology teams improve safety and care for future patients.
Sacramento, CaliforniaAges 18 years+ - NCT05279170Recruiting
Mask anesthesia with gentle throat pressure to prevent stomach air
This trial studies a way to hold gentle pressure near the throat during mask anesthesia (with or without a breathing tube) to reduce air going into the stomach. It may help lower the chance of “stomach insufflation” during elective surgery in young children.
LilleAges 2–10 - NCT04284943Recruiting
Surgery for stomach cancer and diabetes
This trial tests a surgery for early-stage stomach cancer that also aims to improve type 2 diabetes by changing how your body processes food. It might be an option if you have both conditions and are not using insulin.
SeoulAges 20–69 - NCT04674267Recruiting
REACH study for older adults with GI cancer and support needs
This study looks at how to improve health and care support for people age 70 and older with gastrointestinal (GI) cancer. It may help by offering a structured way to address practical and emotional challenges that can affect aging and cancer care.
Boston, MassachusettsAges 70 years+ - NCT06228963RecruitingPhase 2
Orelabrutinib for H. pylori-positive gastric MALT lymphoma
This trial tests a targeted drug called orelabrutinib for people with a specific type of stomach lymphoma that is linked to an active H. pylori infection. The goal is to see if the drug can help shrink or control the lymphoma.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT07705334RecruitingPhase 1
Study of SHY-ONC6 for advanced solid tumors
This trial tests a new drug called SHY-ONC6 that targets and breaks down cancer cells. It's for people with advanced solid tumors that haven't responded to standard treatments.
Scottsdale, ArizonaAges 18 years+ - NCT06743867RecruitingPhase 1
Chemotherapy mist for cancer spread in the belly
This trial tests a new way to give chemotherapy directly into the belly as a fine mist (called PIPAC) for people whose cancer has spread there. The goal is to see if it’s safe and helps shrink or control the cancer.
Guangzhou, GuangdongAges 18–75 - NCT06039917Recruiting
Automatic reminders for stomach precancer follow-up
This study tests whether an automatic reminder system can help more people with stomach precancerous changes get the follow-up checks they need after an upper endoscopy. The goal is to see if the system improves how often patients return for surveillance.
Quanzhou, FujianAges 18 years+ - NCT05790733Recruiting
Communication training versus usual care for feeding tube placement
This study compares a special communication approach to the usual method when placing a naso-gastric (feeding) tube in people receiving chemotherapy. It aims to see whether better communication can make tube placement easier and more tolerable.
Rennes, Brittany RegionAges 18 years+ - NCT03467581Recruiting
Five-year follow-up after laparoscopic stomach sleeve surgery
This study looks at how people do over the next five years after getting laparoscopic (keyhole) gastric sleeve surgery for obesity. It may help doctors understand long-term outcomes and benefits for future patients.
TartuAges 18–65 - NCT05387005Recruiting
Check who should be tested for H. pylori to prevent stomach cancer
This study looks at a screening plan to prevent stomach cancer by identifying people who should be tested and treated for H. pylori, a common stomach germ. If you have never had H. pylori testing or treatment, the trial may help determine the best approach for prevention.
TaipeiAges 20 years+ - NCT05620732Recruiting
CAR-T treatment for advanced stomach or pancreatic cancer
This trial tests a customized immune-cell treatment (CAR-T) for advanced stomach or pancreatic cancer that cannot be removed by surgery. It aims to use cells engineered to target a specific tumor marker to shrink cancer or slow its growth.
Shenzhen, GuangdongAges 18–75 - NCT04295473Recruiting
Test of smaller-incision stomach surgery for gastric cancer
This trial studies a stomach cancer surgery done with fewer/smaller incisions (laparoscopic with reduced ports). It may help people with certain early-to-mid stage stomach cancers by comparing whether this approach is safe and effective for them.
Nanchong, SichuanAges 18–90 - NCT04306458Recruiting
Testing robot-assisted vs standard surgery for resectable esophageal cancer
This trial compares a robot-assisted approach to a standard minimally invasive approach for surgery in people with certain types of esophageal or gastroesophageal junction cancer that can be removed. It aims to see which surgery method works better and is safer for these patients.
MainzAges 18–90 - NCT06654219Recruiting
Clear liquids before endoscopy for patients on GLP-1 meds
This study tests whether drinking only clear liquids before an upper endoscopy can reduce leftover stomach contents in people taking GLP-1 medications (like Ozempic or Mounjaro). It may help make the procedure safer.
Houston, TexasAges 18 years+
Hear when a new Gastric or Gastroesophageal Junction Adenocarcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for gastric or gastroesophageal junction adenocarcinoma?
- Yes. Clin2 currently lists 972 recruiting gastric or gastroesophageal junction adenocarcinoma studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a gastric or gastroesophageal junction adenocarcinoma trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a gastric or gastroesophageal junction adenocarcinoma trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
- Gastric / Gastroesophageal Junction Adenocarcinoma
- AFP Gastric or Gastroesophageal Junction Adenocarcinoma
- Gastric Cancer or Gastroesophageal Junction Adenocarcinoma
- Gastric and Gastroesophageal Junction (GEJ) Adenocarcinoma
- Gastroesophageal Junction Adenocarcinoma
- Metastatic Gastroesophageal Junction Adenocarcinoma
- Gastroesophageal Junction (GEJ) Adenocarcinoma
- Advanced Gastroesophageal Junction Adenocarcinoma
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.